Get an alert when LIFE SCIENCES (UK) HOLDINGS II LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£308K

-21.2% vs 2024

Net assets

£159M

+31.4% highest in 3 filed years

Employees

0

Average over period

Profit before tax

-£26M

+76.4% highest in 3 filed years

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover
Operating profit -£28,519,593-£110,148,263-£25,640,453 +76.7%
Profit before tax -£28,912,426-£110,606,796-£26,129,518 +76.4%
Net profit -£28,916,606-£110,607,116-£26,129,518 +76.4%
Cash £287,309£391,016£308,094 -21.2%
Total assets less current liabilities £138,812,261£128,564,191£159,122,286 +23.8%
Net assets £131,421,370£121,055,444£159,122,286 +31.4%
Equity £131,421,370£121,055,444£159,122,286 +31.4%
Average employees 000
Wages
Directors' remuneration £0£0£0

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Return on capital employed -20.5%-85.7%-16.1%
Gearing (liabilities / total assets) 18.8%6.3%5.9%
Current ratio 0.81x1.67x0.03x
Interest cover -72.60x-52.43x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
PricewaterhouseCoopers CI LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“In assessing whether the going concern basis of preparation is appropriate to adopt, the Directors have not identified events or conditions that may cast significant doubt on the Group's ability to be a going concern. Having considered all of the above, the Directors have considered the cash flow needs of the Group for the next 12 months, and believe the going concern basis of preparation is appropriate.”

Group structure

  1. LIFE SCIENCES (UK) HOLDINGS II LIMITED · parent
    1. Snowsfields Holdings Limited 100% · United Kingdom · real estate investment
    2. Victoria House Holdings Limited 100% · United Kingdom · real estate investment
    3. Oxford Biocitech Holdings Limited 100% · United Kingdom · real estate investment
    4. Pills TopCo SCI 1% · France · real estate investment

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 7 resigned

Name Role Appointed Born Nationality
GEN II CORPORATE SERVICES (JERSEY) LIMITED Corporate Secretary 2022-10-27
DREXLER, Jay Director 2024-12-20 Aug 1984 Canadian
EVERALL, Robin James Ele William Director 2022-10-07 Dec 1980 English
Show 7 resigned officers
Name Role Appointed Resigned
CRESTBRIDGE UK LIMITED Corporate Secretary 2021-12-06 2022-10-27
HODGETTS, Ann Mary Director 2021-12-06 2023-05-22
LAMBERT, Alison Jane, Ms. Director 2021-12-06 2022-10-01
RAWLINSON, Rebecca Mary Director 2024-02-01 2025-04-24
SHAPIRO, Abigail Jane Director 2023-05-19 2024-12-20
SHEARER, Henry Charles Director 2022-02-24 2022-07-19
WOODRING, Antara Director 2025-07-22 2026-06-05

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Re International Corporation Corporate entity Voting 75–100% (as firm), Appoints directors (as firm) 2021-12-06 Active
Life Sciences Holdings Uk Scsp Corporate entity Shares 75–100% (as firm) 2021-12-06 Active

Filing timeline

Last 20 of 83 total filings

Date Type Category Description
2026-06-27 AA accounts Accounts with accounts type group
2026-06-09 TM01 officers Termination director company with name termination date PDF
2026-05-29 SH01 capital Capital allotment shares PDF
2026-03-19 SH01 capital Capital allotment shares PDF
2026-03-19 SH01 capital Capital allotment shares PDF
2026-02-06 SH01 capital Capital allotment shares PDF
2026-01-22 SH01 capital Capital allotment shares PDF
2026-01-22 SH01 capital Capital allotment shares PDF
2026-01-22 SH01 capital Capital allotment shares PDF
2025-12-08 CS01 confirmation-statement Confirmation statement with updates PDF
2025-12-03 SH01 capital Capital allotment shares PDF
2025-11-07 AAMD accounts Accounts amended with accounts type group
2025-11-03 SH01 capital Capital allotment shares PDF
2025-08-26 SH01 capital Capital allotment shares PDF
2025-08-06 AA accounts Accounts with accounts type group
2025-08-01 SH01 capital Capital allotment shares PDF
2025-07-22 AP01 officers Appoint person director company with name date PDF
2025-07-21 SH01 capital Capital allotment shares PDF
2025-07-10 SH01 capital Capital allotment shares PDF
2025-05-22 SH01 capital Capital allotment shares PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
19

last 12 months

Capital events
14

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page